• 1. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 2. Distinction of trans–cis photoisomers with comparable optical properties in multiple-state photochromic systems – examining a molecule with three azobenzenes via in situ irradiation NMR spectroscopy?
  Jonas Kind,Lukas Kaltschnee,Martin Leyendecker,Christina M. Thiele Chem. Commun., 2016,52, 12506-12509
• 3. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 4. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 5. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Methylpyridines

Introduction to 3-Bromo-4-methyl-5-(trifluoromethyl)pyridine (CAS No. 1211518-50-1)

3-Bromo-4-methyl-5-(trifluoromethyl)pyridine (CAS No. 1211518-50-1) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique bromo, methyl, and trifluoromethyl substituents on a pyridine ring, exhibits a range of chemical properties that make it an attractive candidate for various applications, including drug discovery and synthetic intermediates.

The molecular structure of 3-Bromo-4-methyl-5-(trifluoromethyl)pyridine is composed of a pyridine ring with a bromine atom at the 3-position, a methyl group at the 4-position, and a trifluoromethyl group at the 5-position. The presence of these functional groups imparts distinct reactivity and physical properties to the molecule, making it suitable for a variety of chemical transformations and biological studies.

In recent years, the interest in 3-Bromo-4-methyl-5-(trifluoromethyl)pyridine has been driven by its potential as a building block in the synthesis of bioactive molecules. The bromo substituent provides a convenient handle for further functionalization through cross-coupling reactions, such as Suzuki-Miyaura coupling and Stille coupling. These reactions enable the introduction of diverse substituents, expanding the scope of possible derivatives and their biological activities.

The trifluoromethyl group is particularly noteworthy due to its strong electron-withdrawing effect and hydrophobic nature. These properties can influence the pharmacokinetics and pharmacodynamics of molecules containing this moiety. For instance, trifluoromethylated compounds often exhibit enhanced metabolic stability and improved binding affinity to biological targets, making them valuable in drug design.

Research on 3-Bromo-4-methyl-5-(trifluoromethyl)pyridine has also focused on its potential as an intermediate in the synthesis of agrochemicals. The combination of bromo and trifluoromethyl functionalities can lead to compounds with potent herbicidal or pesticidal activities. Studies have shown that derivatives of this compound can effectively target specific enzymes or receptors in plant or insect cells, providing new avenues for developing environmentally friendly agrochemicals.

In the context of medicinal chemistry, 3-Bromo-4-methyl-5-(trifluoromethyl)pyridine has been explored as a scaffold for designing novel therapeutic agents. For example, recent studies have investigated its use in the development of inhibitors for various protein kinases, which are key targets in cancer therapy. The ability to modulate kinase activity through precise structural modifications makes this compound a promising lead for further optimization.

The synthetic accessibility of 3-Bromo-4-methyl-5-(trifluoromethyl)pyridine is another factor contributing to its popularity in research laboratories. Several efficient synthetic routes have been developed to produce this compound on both small and large scales. One common approach involves the bromination of 4-methyl-5-(trifluoromethyl)pyridine using N-bromosuccinimide (NBS), followed by purification through column chromatography or recrystallization.

The physical properties of 3-Bromo-4-methyl-5-(trifluoromethyl)pyridine, such as its melting point, boiling point, and solubility in various solvents, are well-documented in the literature. These properties are crucial for optimizing reaction conditions and ensuring high yields during synthesis. Additionally, spectroscopic techniques such as NMR (Nuclear Magnetic Resonance) and MS (Mass Spectrometry) are routinely used to characterize this compound and confirm its identity.

In conclusion, 3-Bromo-4-methyl-5-(trifluoromethyl)pyridine (CAS No. 1211518-50-1) is a highly versatile compound with significant potential in multiple areas of chemical and pharmaceutical research. Its unique combination of functional groups offers opportunities for developing new bioactive molecules with improved pharmacological profiles. As research continues to advance, it is likely that this compound will play an increasingly important role in the discovery and development of novel therapeutic agents and agrochemicals.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)